ETS2 pathway - PubMed (original) (raw)

Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway

Mao Li et al. Cancer Res. 2007.

Abstract

The oncoprotein MDM2, a major ubiquitin E3 ligase of tumor suppressor p53, has been suggested as a novel target for human cancer therapy based on its p53-dependent and p53-independent activities. We have identified curcumin, which has previously been shown to have anticancer activity, as an inhibitor of MDM2 expression. Curcumin down-regulates MDM2, independent of p53. In a human prostate cancer cell lines PC3 (p53(null)), curcumin reduced MDM2 protein and mRNA in a dose- and time-dependent manner, and enhanced the expression of the tumor suppressor p21(Waf1/CIP1). The inhibitory effects occur at the transcriptional level and seem to involve the phosphatidylinositol 3-kinase/mammalian target of rapamycin/erythroblastosis virus transcription factor 2 pathway. Curcumin induced apoptosis and inhibited proliferation of PC3 cells in culture, but both MDM2 overexpression and knockdown reduced these effects. Curcumin also inhibited the growth of these cells and enhanced the cytotoxic effects of gemcitabine. When it was administered to tumor-bearing nude mice, curcumin inhibited growth of PC3 xenografts and enhanced the antitumor effects of gemcitabine and radiation. In these tumors, curcumin reduced the expression of MDM2. Down-regulation of the MDM2 oncogene by curcumin is a novel mechanism of action that may be essential for its chemopreventive and chemotherapeutic effects. Our observations help to elucidate the process by which mitogens up-regulate MDM2, independent of p53, and identify a mechanism by which curcumin functions as an anticancer agent.

PubMed Disclaimer

Cited by

FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.
Haque A, Rahman MA, Fuchs JR, Chen ZG, Khuri FR, Shin DM, Amin AR. Haque A, et al. Cancer Lett. 2015 Jul 28;363(2):166-75. doi: 10.1016/j.canlet.2015.04.017. Epub 2015 Apr 24. Cancer Lett. 2015. PMID: 25917567 Free PMC article.
Curcumin AntiCancer Studies in Pancreatic Cancer.
Bimonte S, Barbieri A, Leongito M, Piccirillo M, Giudice A, Pivonello C, de Angelis C, Granata V, Palaia R, Izzo F. Bimonte S, et al. Nutrients. 2016 Jul 16;8(7):433. doi: 10.3390/nu8070433. Nutrients. 2016. PMID: 27438851 Free PMC article. Review.
Curcumin Remedies Testicular Function and Spermatogenesis in Male Mice with Low-Carbohydrate-Diet-Induced Metabolic Dysfunction.
Tsao CW, Ke PS, Yang HY, Chang TC, Liu CY. Tsao CW, et al. Int J Mol Sci. 2022 Sep 2;23(17):10009. doi: 10.3390/ijms231710009. Int J Mol Sci. 2022. PMID: 36077406 Free PMC article.
Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells.
Pesakhov S, Khanin M, Studzinski GP, Danilenko M. Pesakhov S, et al. Nutr Cancer. 2010;62(6):811-24. doi: 10.1080/01635581003693082. Nutr Cancer. 2010. PMID: 20661831 Free PMC article.
Targeting MDM2 for novel molecular therapy: Beyond oncology.
Wang W, Qin JJ, Rajaei M, Li X, Yu X, Hunt C, Zhang R. Wang W, et al. Med Res Rev. 2020 May;40(3):856-880. doi: 10.1002/med.21637. Epub 2019 Oct 6. Med Res Rev. 2020. PMID: 31587329 Free PMC article. Review.

Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway - PubMed (original) (raw)